Patología Vascular y Trombosis
VYTRO
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (13)
2019
-
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
BMC neurology, Vol. 19, Núm. 1, pp. 167
-
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
Journal of Critical Care, Vol. 51, pp. 117-121
2015
-
Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
Critical Care, Vol. 19, Núm. 1
-
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction
BMC Neurology, Vol. 15, Núm. 1
2014
-
Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury
PLoS ONE, Vol. 9, Núm. 4
-
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio
PLoS ONE, Vol. 9, Núm. 4
-
Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients
Thrombosis Research, Vol. 134, Núm. 1, pp. 182-186
2013
2011
-
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Critical Care, Vol. 15, Núm. 2
2010
2009
2008
-
D-dimer level is not a prognostic biomarker specific of pulmonary embolism [5]
Critical Care Medicine
2007
-
D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry
Critical Care Medicine, Vol. 35, Núm. 8, pp. 1937-1941